MedTrace Logo

Observational Study on the Diagnostic Evaluation of the Intestinal Microbiota of Patients With COVID-19.

NCT05107245 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 143

Last updated 2021-12-20

No results posted yet for this study

Summary

In the context of the COVID-19 pandemic, the role of the gut microbiome is yet unknown. The aim of this trial is to evaluate the clinical contribution of the gut microbiome composition and diversity on the disease severity and to estimate the viral load in stool samples.

Conditions

Interventions

DIAGNOSTIC_TEST

1test1

Loss of bacterial diversity diagnosis

Sponsors & Collaborators

  • Clinique Saint Jean Ermitage

    collaborator UNKNOWN

  • Nantes University Hospital

    collaborator OTHER

  • Centre Hospitalier de Fontainebleau

    collaborator UNKNOWN

  • Clinique du Mousseau

    collaborator UNKNOWN

  • Luxia Scientific

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-28
Primary Completion
2021-04-29
Completion
2021-05-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05107245 on ClinicalTrials.gov